These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22702953)

  • 21. Structure of human TRPV4 in complex with GTPase RhoA.
    Nadezhdin KD; Talyzina IA; Parthasarathy A; Neuberger A; Zhang DX; Sobolevsky AI
    Nat Commun; 2023 Jun; 14(1):3733. PubMed ID: 37353478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
    J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural insight into the assembly of TRPV channels.
    Huynh KW; Cohen MR; Chakrapani S; Holdaway HA; Stewart PL; Moiseenkova-Bell VY
    Structure; 2014 Feb; 22(2):260-8. PubMed ID: 24373766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PACSINs bind to the TRPV4 cation channel. PACSIN 3 modulates the subcellular localization of TRPV4.
    Cuajungco MP; Grimm C; Oshima K; D'hoedt D; Nilius B; Mensenkamp AR; Bindels RJ; Plomann M; Heller S
    J Biol Chem; 2006 Jul; 281(27):18753-62. PubMed ID: 16627472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the N-terminal ankyrin repeat domain of the TRPV2 ion channel.
    Jin X; Touhey J; Gaudet R
    J Biol Chem; 2006 Sep; 281(35):25006-10. PubMed ID: 16809337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of TRPV4 by diverse mechanisms.
    Darby WG; Grace MS; Baratchi S; McIntyre P
    Int J Biochem Cell Biol; 2016 Sep; 78():217-228. PubMed ID: 27425399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The amino-terminal domain of TRPV4 channel is involved in its trafficking to the nucleus.
    Méndez-Gómez S; Espadas-Álvarez H; Ramírez-Rodríguez I; Domínguez-Malfavón L; García-Villegas R
    Biochem Biophys Res Commun; 2022 Feb; 592():13-17. PubMed ID: 35007845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Zinc-Finger Domain Containing Protein ZC4H2 Interacts with TRPV4, Enhancing Channel Activity and Turnover at the Plasma Membrane.
    Vangeel L; Janssens A; Lemmens I; Lievens S; Tavernier J; Voets T
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.
    Mah W; Sonkusare SK; Wang T; Azeddine B; Pupavac M; Carrot-Zhang J; Hong K; Majewski J; Harvey EJ; Russell L; Chalk C; Rosenblatt DS; Nelson MT; Séguin C
    J Med Genet; 2016 Oct; 53(10):705-9. PubMed ID: 27330106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATP modulates Ca2+ uptake by TRPV6 and is counteracted by isoform-specific phosphorylation.
    Al-Ansary D; Bogeski I; Disteldorf BM; Becherer U; Niemeyer BA
    FASEB J; 2010 Feb; 24(2):425-35. PubMed ID: 19805577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Asparaginyl beta-hydroxylation of proteins containing ankyrin repeat domains influences their stability and function.
    Hardy AP; Prokes I; Kelly L; Campbell ID; Schofield CJ
    J Mol Biol; 2009 Oct; 392(4):994-1006. PubMed ID: 19646994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Pharmacology of TRPV4 Antagonists.
    Fan J; Guo C; Liao D; Ke H; Lei J; Xie W; Tang Y; Tominaga M; Huang Z; Lei X
    Adv Sci (Weinh); 2024 Jul; 11(25):e2401583. PubMed ID: 38659239
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Channelopathies converge on TRPV4.
    Nilius B; Owsianik G
    Nat Genet; 2010 Feb; 42(2):98-100. PubMed ID: 20104247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interdomain interactions control Ca2+-dependent potentiation in the cation channel TRPV4.
    Strotmann R; Semtner M; Kepura F; Plant TD; Schöneberg T
    PLoS One; 2010 May; 5(5):e10580. PubMed ID: 20485495
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular and topological membrane folding determinants of transient receptor potential vanilloid 2 channel.
    Doñate-Macian P; Bañó-Polo M; Vazquez-Ibar JL; Mingarro I; Perálvarez-Marín A
    Biochem Biophys Res Commun; 2015 Jul; 462(3):221-6. PubMed ID: 25956061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in calmodulin-binding domains of TRPV4/6 channels confer invasive properties to colon adenocarcinoma cells.
    Arbabian A; Iftinca M; Altier C; Singh PP; Isambert H; Coscoy S
    Channels (Austin); 2020 Dec; 14(1):101-109. PubMed ID: 32186440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRPV4 mediates hypotonicity-induced ATP release by the thick ascending limb.
    Silva GB; Garvin JL
    Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1090-5. PubMed ID: 18684885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of novel mutation in TRPV4 with familial nonsyndromic craniosynostosis with complete penetrance and variable expressivity.
    Gayden T; Crevier-Sorbo G; Jawhar W; Saint-Martin C; Eveleigh R; Gilardino MS; Anastasio N; Trakadis Y; Bassenden AV; Berghuis AM; Jabado N; Dudley RWR
    J Neurosurg Pediatr; 2023 Jun; 31(6):584-592. PubMed ID: 36905673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryo-electron microscopy structure of the TRPV2 ion channel.
    Zubcevic L; Herzik MA; Chung BC; Liu Z; Lander GC; Lee SY
    Nat Struct Mol Biol; 2016 Feb; 23(2):180-186. PubMed ID: 26779611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IP3 receptor binds to and sensitizes TRPV4 channel to osmotic stimuli via a calmodulin-binding site.
    Garcia-Elias A; Lorenzo IM; Vicente R; Valverde MA
    J Biol Chem; 2008 Nov; 283(46):31284-8. PubMed ID: 18826956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.